ConductScience.org, home

Comparison · NCT04296396-b5276bc5

Individualized Opioid Prescription Protocol (IOPP) vs Fixed Opioid Prescription: Number of Participants Who Indicated an Improved Global Impression of Change

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Individualized Opioid Prescription Protocol (IOPP) vs Fixed Opioid Prescription: Number of Participants Who Indicated an Improved Global Impression of Change. Trial comparisons, record NCT04296396-b5276bc5. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04296396-b5276bc5

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.9640.9560.97wilson
Risk in group 20.9710.9640.977wilson
Risk difference, group 1 minus group 2-0.0073-0.01730.00258newcombe hybrid score
Risk ratio, group 1 over group 20.9920.9821log
Odds ratio, group 1 over group 20.7930.5811.08log
Number needed to treat, for one fewer participant with the outcome on Individualized Opioid Prescription Protocol (IOPP) than on Fixed Opioid Prescription137from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Individualized Opioid Prescription Protocol (IOPP)
Individualized opioid prescription protocol (IOPP) with shared decision making. IOPP will be based on inpatient oral opioid intake during the 24 hour period prior to randomization and should not include the 12 hours immediately after the cesarean.
2,4362,528OG000
Group 2Fixed Opioid PrescriptionFixed amount of opioids (20 tablets of oxycodone 5mg)2,4362,509OG001

Outcome

Type
SECONDARY
Title
Number of Participants Who Indicated an Improved Global Impression of Change
Description
Number of participants who indicated an improved global impression of change in overall pain at 2 weeks post-discharge. This represents a selection on a multiple choice survey question with the response options: very much improved, much improved, minimally improved, no change, minimally worse, much worse, very much worse.
Time frame
2 weeks post discharge
Population

Source ClinicalTrials.gov

Trial

Title
Opioid Prescription After Cesarean Trial
NCT number
NCT04296396
Phases
PHASE3
Conditions
Pregnancy Related, Opioid Use, Pain
Interventions
0 to 20 tablets of oxycodone 5mg, Fixed opioid prescription
Lead sponsor
The George Washington University Biostatistics Center
Results first posted
2023-10-03

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04296396-b5276bc5